Zullo Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$426K Buy
1,210
+5
+0.4% +$1.78K 0.16% 101
2025
Q4
$395K Sell
1,205
-123
-9% -$39K 0.14% 105
2025
Q3
$375K Sell
1,328
-7
-0.5% -$2.03K 0.14% 108
2025
Q2
$373K Sell
1,335
-27
-2% -$7.65K 0.15% 103
2025
Q1
$424K Sell
1,362
-2
-0.1% -$591 0.18% 96
2024
Q4
$356K Buy
1,364
+37
+3% +$11K 0.14% 105
2024
Q3
$428K Sell
1,327
-24
-2% -$7.85K 0.18% 94
2024
Q2
$422K Sell
1,351
-1
-0.1% -$294 0.19% 93
2024
Q1
$384K Buy
1,352
+13
+1% +$3.8K 0.18% 101
2023
Q4
$386K Sell
1,339
-35
-3% -$9.54K 0.2% 98
2023
Q3
$369K Sell
1,374
-19
-1% -$4.74K 0.22% 94
2023
Q2
$309K Buy
1,393
+18
+1% +$4.18K 0.18% 105
2023
Q1
$333K Buy
1,375
+3
+0.2% +$736 0.21% 98
2022
Q4
$360K Buy
1,372
+6
+0.4% +$1.61K 0.22% 89
2022
Q3
$308K Buy
1,366
+42
+3% +$10.2K 0.2% 91
2022
Q2
$322K Sell
1,324
-11
-0.8% -$2.7K 0.2% 94
2022
Q1
$323K Buy
1,335
+3
+0.2% +$689 0.17% 112
2021
Q4
$300K Buy
+1,332
New +$281K 0.15% 119

Other funds holding AMGN

Zullo Investment Group's AMGN Position: Q1 2026 in Review

Zullo Investment Group increased its Amgen (AMGN) stake by 0.41% in Q1 2026, buying an estimated $1.78K and bringing the position to 1,210 shares worth $426K. The position accounts for 0.16% of the portfolio, ranked #101.

Zullo Investment Group first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $428K in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Zullo Investment Group held 1,210 shares of Amgen worth $426K as of Q1 2026.
  • Zullo Investment Group bought 5 Amgen shares in Q1 2026, an estimated $1.78K.
  • Amgen made up 0.16% of Zullo Investment Group's portfolio in Q1 2026, its #101 holding.
  • Zullo Investment Group first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Zullo Investment Group's Amgen position peaked at $428K in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Zullo Investment Group's 13F filing for Q1 2026, filed 15 Apr 2026.